Is the aging process accelerated in chronic obstructive pulmonary disease?

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 2, 2011, Pages 90-97

  Lee, Jee ^a   Sandford, Andrew ^a   Man, Paul ^a   Sin, Don D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

aging; COPD; senescence; telomere

Indexed keywords

FREE RADICAL; GELATINASE B; REGUCALCIN; SIRTUIN 1; SURFACTANT PROTEIN D; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTERIAL OXYGEN SATURATION; ARTICLE; CELL AGING; CELL SIZE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DNA DAMAGE; DNA SEQUENCE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; FORCED EXPIRATORY VOLUME; HUMAN; IN VITRO STUDY; LUNG ALVEOLUS CELL; LUNG EMPHYSEMA; LUNG FIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL CIRCULATION; RADIATION EXPOSURE; SENESCENCE; SOUTHERN BLOTTING; SUN EXPOSURE; TELOMERE; WRINKLE;

AGING; BIOLOGICAL MARKERS; BLOTTING, SOUTHERN; CELL AGING; DISEASE PROGRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOCYTES; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TELOMERE;

EID: 79951679556     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328341cead     Document Type: Article

References (86)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555. (Pubitemid 47403272)
2. Van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75:224-238. (Pubitemid 351363881)
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2009. Available at http://www.goldcopd.com/Guidelineitem. asp?l1=2&l2=1&intId=2003 [accessed 10 April 2010].
4. Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72:1016-1023.
5. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278:1355-1360.
6. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967; 22:95-108.
7. Berger JS, Sanborn TA, Sherman W, Brown DL. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol 2004; 94:649-651. (Pubitemid 39165849)
8. Ryu YJ, Chun EM, Lee JH, Chang JH. Prevalence of depression and anxiety in outpatients with chronic airway lung disease. Korean J Intern Med 2010; 25:51-57.
9. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3:637-658.
10. Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:1259-1265. (Pubitemid 46905751)
11. Zielinski J. Circumstances of death in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1998; 53:324-330. (Pubitemid 28461664)
12. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28:1245-1257. (Pubitemid 44883863)
13. Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009; 135:173-180.
14. MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans 2009; 37 (Pt 4):819-823.
15. Karrasch S, Holz O, Jorres RA. Aging and induced senescence as factors in the pathogenesis of lung emphysema. Respir Med 2008; 102:1215-1230.
16. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37:614-636.
17. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 2006; 1067:10-21. (Pubitemid 43806304)
18. Head E, Rofina J, Zicker S. Oxidative stress, aging, and central nervous system disease in the canine model of human brain aging. Vet Clin North Am Small Anim Pract 2008; 38:167-178; vi. (Pubitemid 351176589)
19. Percy CJ, Power D, Gobe GC. Renal ageing: changes in the cellular mechanism of energy metabolism and oxidant handling. Nephrology (Carlton) 2008; 13:147-152. (Pubitemid 351229633)
20. Galaris D, Mantzaris M, Amorgianiotis C. Oxidative stress and aging: the potential role of iron. Hormones (Athens) 2008; 7:114-122.
21. Reeve AK, Krishnan KJ, Turnbull DM. Age related mitochondrial degenerative disorders in humans. Biotechnol J 2008; 3:750-756.
22. Von Zglinicki T, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995; 220:186-193.
23. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298-300.
24. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621.
25. Shapiro SD. The pathogenesis of emphysema: the elastase : antielastase hypothesis 30 years later. Proc Assoc Am Phys 1995; 107:346-352.
26. Shapiro SD, Ingenito EP. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol 2005; 32:367-372. (Pubitemid 40629320)
27. Aoshiba K, Nagai A. Chronic lung inflammation in aging mice. FEBS Lett 2007; 581:3512-3516. (Pubitemid 47048210)
28. Kaszubowska L. Telomere shortening and ageing of the immune system. J Physiol Pharmacol 2008; 59 (Suppl. 9):169-186.
29. Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 2006; 5:136-139. (Pubitemid 43129545)
30. Goronzy JJ, Weyand CM. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 2003; 5:225-234. (Pubitemid 37139037)
31. Lambers C, Hacker S, Posch M, et al. T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease. Clin Exp Immunol 2009; 155:466-475.
32. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13:567-569. (Pubitemid 46828488)
33. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999; 13:197-205. (Pubitemid 29079244)
34. Verbeken EK, Cauberghs M, Mertens I, et al. The senile lung. Comparison with normal and emphysematous lungs. 2: Functional aspects. Chest 1992; 101:800-809.
35. Tsuji T, Aoshiba K, Nagai A. Cigarette smoke induces senescence in alveolar epithelial cells. Am J Respir Cell Mol Biol 2004; 31:643-649. (Pubitemid 39587494)
36. Muller KC, Welker L, Paasch K, et al. Lung fibroblasts from patients with emphysema show markers of senescence in vitro. Respir Res 2006; 7:32.
37. Holz O, Zuhlke I, Jaksztat E, et al. Lung fibroblasts from patients with emphysema show a reduced proliferation rate in culture. Eur Respir J 2004; 24:575-579. (Pubitemid 39406130)
38. Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 2006; 174:530-537. (Pubitemid 44330545)
39. Suga T, Kurabayashi M, Sando Y, et al. Disruption of the Klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life. Am J Respir Cell Mol Biol 2000; 22:26-33. (Pubitemid 30342956)
40. Funada Y, Nishimura Y, Yokoyama M. Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho mice. Kobe J Med Sci 2004; 50:59-67. (Pubitemid 41007603)
41. Yang SR, Wright J, Bauter M, et al. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol 2007; 292:L567-L576.
42. Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:861-870. (Pubitemid 351600664)
43. Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988; 85:6622-6626.
44. Munoz P, Blanco R, Blasco MA. Role of the TRF2 telomeric protein in cancer and ageing. Cell Cycle 2006; 5:718-721.
45. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991; 256:271-282.
46. Levy MZ, Allsopp RC, Futcher AB, et al. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225:951-960.
47. Olovnikov AM. Principle of marginotomy in template synthesis of polynucleotides. Dokl Akad Nauk SSSR 1971; 201:1496-1499.
48. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973; 41:181-190.
49. Watson JD. Origin of concatemeric T7 DNA. Nat New Biol 1972; 239:197-201.
50. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres: relation to aging. Proc Natl Acad Sci U S A 1995; 92:258-262.
51. Von Zglinicki T, Pilger R, Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med 2000; 28:64-74. (Pubitemid 30045574)
52. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27:339-344. (Pubitemid 34756516)
53. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989; 337:331-337.
54. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995; 219:130-136.
55. Capezzone M, Cantara S, Marchisotta S, et al. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients. J Clin Endocrinol Metab 2008; 93:3950-3957.
56. Blasco MA. Mammalian telomeres and telomerase: why they matter for cancer and aging. Eur J Cell Biol 2003; 82:441-446. (Pubitemid 37266043)
57. Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ. Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med 2008; 44:235-246.
58. Huda N, Tanaka H, Herbert BS, et al. Shared environmental factors associated with telomere length maintenance in elderly male twins. Aging Cell 2007; 6:709-713. (Pubitemid 47400052)
59. Cawthon RM, Smith KR, OBrien E, et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361:393-395. (Pubitemid 36164975)
60. Serrano AL, Andres V. Telomeres and cardiovascular disease: does size matter? Circ Res 2004; 94:575-584. (Pubitemid 38387739)
61. Benetos A, Okuda K, Lajemi M, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001; 37 (2 Part 2):381-385. (Pubitemid 32198997)
62. Von Zglinicki T, Serra V, Lorenz M, et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest 2000; 80:1739-1747.
63. Takubo K, Izumiyama-Shimomura N, Honma N, et al. Telomere lengths are characteristic in each human individual. Exp Gerontol 2002; 37:523-531. (Pubitemid 34119157)
64. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003; 95:1211-1218. (Pubitemid 37069551)
65. Broberg K, Bjork J, Paulsson K, et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005; 26:1263-1271. (Pubitemid 41417904)
66. McGrath M, Wong JYY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomark Prev 2007; 16:815-819. (Pubitemid 46650587)
67. Jang JS, Choi YY, Lee WK, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008; 99:1385-1389. (Pubitemid 351761728)
68. Calado RT, Young NS. Telomere diseases. N Engl J Med 2009; 361:2353-2365.
69. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98:503-517.
70. Saldanha SN, Andrews LG, Tollefsbol TO. Assessment of telomere length and factors that contribute to its stability. Eur J Biochem 2003; 270:389-403. (Pubitemid 36177306)
71. Engelhardt M, Drullinsky P, Guillem J, Moore MA. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997; 3:1931-1941. (Pubitemid 27505118)
72. Lansdorp PM, Verwoerd NP, van de Rijke FM, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 1996; 5:685-691. (Pubitemid 26141285)
73. Baerlocher GM, Lansdorp PM. Telomere length measurements using fluorescence in situ hybridisation and flow cytometry. In: Darzynkiewicz Z, Roederer M, Tanke H, editors. Methods in cell biology, 4th ed. Academic Press; pp. 719-750.
74. Zijlmans JM, Martens UM, Poon SS, et al. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci U S A 1997; 94:7423-7428. (Pubitemid 27345331)
75. Londono-Vallejo JA, DerSarkissian H, Cazes L, Thomas G. Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res 2001; 29:3164-3171. (Pubitemid 32750562)
76. Poon SS, Martens UM, Ward RK, Lansdorp PM. Telomere length measurements using digital fluorescence microscopy. Cytometry 1999; 36:267-278. (Pubitemid 29344462)
77. Lauzon W, Sanchez Dardon J, Cameron DW, Badley AD. Flow cytometric measurement of telomere length. Cytometry 2000; 42:159-164. (Pubitemid 30451715)
78. HultdinM, Gronlund E, Norrback K, et al. Telomere analysis by fluorescence in situ hybridization and flow cytometry. Nucleic Acids Res 1998; 26:3651-3656. (Pubitemid 28367969)
79. Braylan RC. Attributes and applications of flow cytometry. Ann Clin Lab Sci 1983; 13:379-384. (Pubitemid 13046885)
80. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47.
81. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009; 37:e21.
82. OCallaghan N, Dhillon V, Thomas P, Fenech M. A quantitative real-time PCR method for absolute telomere length. BioTechniques 2008; 44:807-809. (Pubitemid 351839149)
83. Yokohori N, Aoshiba K, Nagai A, Respiratory Failure Research Group in Japan. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 2004; 125:626-632. (Pubitemid 38223645)
84. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med 2006; 174:886-893. (Pubitemid 44564788)
85. Savale L, Chaouat A, Bastuji-Garin S, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179:566-571.
86. Mui TS, Man JM, McElhaney JE, et al. Telomere length and chronic obstructive pulmonary disease: evidence of accelerated aging. J Am Geriatr Soc 2009; 57:2372-2374.